Literature DB >> 10806802

The protein expression of Bcl-2, Bax, Fas/Apo-1 in acute myeloid leukemia.

J Zhou1, Y Chen, C Li, W Liu.   

Abstract

The protein expression of bcl-2, bax, Fas/Apo-1 in 19 cases of acute myeloid leukemia (AML) were investigated by Western blot and ApAAp techniques. High expression of bcl-2 protein was found in most of the AML cases, and some of the cases expressed Fas/Apo-1 and bax. High expression of bcl-2 protein was associated with a bad clinical prognosis and a poor response after intensive chemotherapy. Bax seemed to coexpress with bcl-2 and so appeared to be a bad prognostic factor instead of a good one. The expression of Fas/Apo-1 was inversely correlated with bcl-2 and seemed to be a good prognostic factor which may reflect the relative homeostasis of apoptotic pathway. It is concluded that apoptosis-induced pathways in AML often exhibit disturbance features. Coregulation of bcl-2, Bax and Fas/Apo-1 genes formed the apoptosis-induced pathway, which is the biological factor affecting response to chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10806802     DOI: 10.1007/bf02888279

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  3 in total

1.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.

Authors:  Z N Oltvai; C L Milliman; S J Korsmeyer
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

2.  Bax mutations in cell lines derived from hematological malignancies.

Authors:  J P Meijerink; T F Smetsers; A W Slöetjes; E H Linders; E J Mensink
Journal:  Leukemia       Date:  1995-11       Impact factor: 11.528

Review 3.  Control of programmed cell death in normal and leukemic cells: new implications for therapy.

Authors:  L Sachs; J Lotem
Journal:  Blood       Date:  1993-07-01       Impact factor: 22.113

  3 in total
  1 in total

1.  C18H17NO6 and Its Combination with Scutellarin Suppress the Proliferation and Induce the Apoptosis of Human Glioma Cells via Upregulation of Fas-Associated Factor 1 Expression.

Authors:  Xiu-Ying He; Liu-Lin Xiong; Xiao-Qiong He; Ting-Hua Wang; Qing-Jie Xia; Yang-Yang Wang; Xiao-Ming Zhao; Ruo-Lan Du; Jin Huang
Journal:  Biomed Res Int       Date:  2019-02-20       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.